Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Biomolecular Analysis for Predicting Response to Regorafenib [NA]
Completed clinical trial evaluating biomolecular markers to predict which glioblastoma patients respond to regorafenib, including the IDH-wi…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Modulation of Ciliogenesis in Glioma Stem Cells [NA]
This clinical trial update reports on a study investigating modulation of ciliogenesis in glioma stem cells for glioblastoma and malignant g…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating stereotactic photodynamic therapy with Gliolan (5-aminolevulinic acid) for adults with recurrent glioblastoma; the …
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Phase I EGFR BATs in Newly Diagnosed Glioblastoma [Phase 1]
A Phase I trial evaluating EGFR BATs in newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors [NA]
Completed update for the BurnAlong Pilot Study evaluating a program for adolescent and young adult cancer survivors. The study spans multipl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluated the safety, efficacy, and pharmacokinetics of boron neutron capture therapy (BNCT) for recurrent high…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas [Phase 1]
Phase 1 trial of INCB7839 in children with recurrent or progressive high-grade gliomas has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating NovoTTF-100A (tumor treating fields) combined with bevacizumab in recurrent glioblastoma has completed with results…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
This completed clinical trial update assesses in situ immune parameters and their prognostic role in the survival of patients with glioblast…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom [NA]
A completed clinical trial assessed accurate dynamic contrast-enhanced MRI measurements of glioblastoma using a point-of-care portable perfu…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas [Phase 1]
Phase 1 trial evaluating GMCI in combination with nivolumab and radiation therapy for newly diagnosed high-grade gliomas has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF) [NA]
This is an ongoing clinical trial evaluating amplitude-modulated radiofrequency electromagnetic field therapy in combination with radiochemo…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery [Phase 1]
A Phase 1 trial update evaluating the safety and efficacy of a dendritic cell vaccine in combination with temozolomide for newly diagnosed g…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma [Phase 1]
This clinical trial update describes a Phase 1 safety and efficacy study of an anti-B7-H3 CAR-T cell therapy for recurrent glioblastoma, spo…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma [Phase 1]
A Phase 1 study evaluating intratumoral MTX110 in patients with recurrent glioblastoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer [NA]
This update reports the completion of a clinical trial evaluating health care coach support to reduce acute care use and costs in cancer pat…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma [Phase 1]
A Phase 1 trial combining partial brain radiotherapy, temozolomide, chloroquine, and tumor treating fields for newly diagnosed glioblastoma …
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions [NA]
This update reports safety and feasibility results from a completed trial investigating MR-guided laser thermal ablation of brain lesions in…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Feasibility of the LUM Imaging System for Detection of Cancer to the Brain [NA]
A feasibility trial of the LUM Imaging System for detecting cancer in the brain has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluating a vaccine therapy for newly diagnosed glioblastoma multiforme has completed, and results have been poste…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM [Phase 2]
Phase 2 study in glioblastoma comparing nivolumab plus standard-dose bevacizumab versus nivolumab plus low-dose bevacizumab; results were po…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma [Phase 1]
Phase 1 trial evaluating the addition of XS15 multi-peptide vaccination to standard postoperative radiotherapy and temozolomide in newly dia…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma [Phase 2]
Phase 2 trial evaluating a telomerase-derived universal cancer peptide vaccine for glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma [Phase 1]
Phase 1 trial evaluating adavosertib in combination with radiation therapy and temozolomide for newly diagnosed or recurrent glioblastoma; t…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oral ONC201 in Adult Recurrent Glioblastoma [Phase 2]
Phase 2 trial of oral ONC201 in adult recurrent glioblastoma was terminated; results have been posted.